InvestSMART

Medical Developments International Limited (ASX:MVP)

ALERT: Price-sensitive ASX Announcement for MVP
Current share price for MVP : $0.410 -0.045 (-9.89%)+
Announcement
Release
19 Feb 2026 8:54AM
Price at Release
$0.455
Full Release
download
Summary
Medical Developments International Limited's FY26 Half Year Report highlights a $0.2 million net loss after tax, with operating activities generating $0.3 million in net cash flow. Despite increased revenue in the Pain Management segment by 18% to $15.4 million, the Respiratory segment saw a 10% revenue decrease. Underlying EBIT reflected a $0.3 million loss, down from a previous profit. The company's net assets slightly declined, reflecting the economic challenges faced during the period.
Key Points
  • Net cash flows generated from operating activities was $0.3 million.
  • Payments for property, plant and equipment totaled $0.2 million.
  • Revenue in the Pain Management segment increased by 18% to $15.4 million.
  • Underlying EBIT was a $0.3 million loss, compared to a $0.2 million profit the previous period.
  • The Respiratory segment revenue decreased by 10% to $6.2 million.
  • Net loss after tax was $0.2 million.
  • Net assets decreased slightly to $54.8 million from $55.1 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.